Related Experiment Video
Updated: May 5, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries
H J Rapold1, A Haeberli, H Kuemmerli
1Thrombosis Research Laboratory, University of Bern Medical School, Switzerland.
Insights
Myocardial infarction with normal coronary arteries involves fibrin formation and platelet activation, similar to cases with significant artery disease. These processes are crucial in the early hours of heart attack, regardless of underlying coronary artery conditions.
Area of Science:
- Cardiology
- Hematology
Background:
- Coronary spasm is suspected in myocardial infarction with normal coronary arteries, but evidence is limited.
- Thrombosis is established in myocardial infarction with coronary artery disease, yet its role in normal arteries is unclear.
Observation:
- Three young men with acute myocardial infarction and normal coronary arteries were studied.
- Plasma levels of fibrinopeptide A (FPA) and beta-thromboglobulin (BTG) were measured before and during thrombolytic therapy.
Findings:
- Elevated FPA and BTG levels indicated fibrin formation and platelet activation in patients with normal coronary arteries.
- These activation markers were comparable to those in patients with severe coronary artery disease.
Implications:
- Fibrin formation and platelet activation appear to be equally important in acute myocardial infarction, irrespective of coronary artery disease.
- This suggests potential therapeutic targets beyond traditional atherosclerosis management for certain heart attack cases.
Abstract:
Coronary spasm is the mechanism most often postulated to explain the rare combination of myocardial infarction and angiographically normal coronary arteries, although the reported evidence for its role is circumstantial rather than conclusive. Whereas the importance of thrombosis in myocardial infarction is uncontested in the presence of significant coronary artery disease, there is little in vivo evidence for thrombosis in angiographically normal coronary arteries. Among 11 consecutive patients with acute myocardial infarction undergoing thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) 3.2 +/- 0.7 h after onset of chest pain, and angiography 10.2 +/- 4.5 days later, three young men had normal coronary arteries. Their cases are documented electrocardiographically, enzymatically and angiographically. Mean plasma levels of fibrinopeptide A (FPA) and beta-thromboglobulin (BTG) were clearly elevated before and during rtPA therapy: FPA 52 +/- 41 ng ml-1, BTG 257 +/- 46 ng ml-1. They did not differ significantly from corresponding mean plasma levels in the eight patients with severe coronary artery disease: FPA 67 +/- 66 ng ml-1, BTG181 +/- 75 ng ml-1. We conclude that fibrin formation and platelet activation are probably equally important in the early hours of myocardial infarction, whether or not significant coronary artery disease is present.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

